Men excluded from two-thirds of breast cancer clinical trials

Traveltext

Oliver Bogler, a male breast cancer survivor and researcher, has recently spoken at a session on Clinical Trials at the annual meeting of the American Society of Breast Surgeons in Dallas. He noted that men are only eligible for one in three breast cancer clinical trials. His conclusion:

"I believe that excluding men from clinical trials for which their disease is a match should require justification in the context of established guidelines for ethical subject selection."

"In other words, if you don't include men you have to come out and say so, and give a reason that is acceptable to medical ethicists and experts in the field. I am sure that there are many situations where that is true, but I bet there are others where men could well be included, and as a result we may learn new things about their disease and how to treat it."

More HERE.